It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
In need of cash assistance? Explore various ways to secure quick cash to help you through tough financial times.
21,137 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
IBM is attracting fresh investor attention as its AI infrastructure strategy gains traction. Arvind Krishna’s reshape...
New data show that gray divorce standard living often declines sharply for older women after separation, making Socia...
A typical $1 million nest egg may translate to roughly $28k of discretionary annual spending after taxes, Medicare, a...
NVIDIA stock has surprised some by not rallying in 2026 despite booming AI demand. This article breaks down why the s...
Archer Aviation sits at a pivotal crossroads as FAA progress updates loom and defense contracts lurk in the wings. Th...
SoFi Technologies posted record fourth-quarter results and added a million members, yet the stock sits around $18. Th...
New financing dynamics push builder optimism into 2026 even as demand concerns persist. A key survey shows a structur...
Dell Technologies grabbed headlines as its AI-focused strategy started to show momentum. This piece breaks down why d...
Moderna and Ross Stores surged midweek on distinct catalysts: a patent settlement clearing a key overhang for Moderna...
AI-powered pricing is moving from experiment to everyday practice at Walmart. This article explains how walmart rolls...
Trump Media & Technology Group pivots from traditional media toward a Bitcoin treasury, with 2025 revenue of $3.7 mil...